“‘It’s probably too late once the effects of neurodegeneration are manifest,’ explains Marc Diamond, Director of UT Southwestern’s Center for Alzheimer’s and Neurodegenerative Diseases.
‘We need to be able to diagnose the process early and know the specific type of neurodegeneration that is occurring, because that is the best chance we have to intervene with a personalized treatment. This is very analogous to how we currently use tumor genotyping to best diagnose and treat cancer.'”
Read the full story at newatlas.com
A single molecule could forecast what type of dementia a person will develop | New Atlas
More from ResearchMore posts in Research »
- A possible blood test for early-stage Alzheimer’s disease | Medical Xpress
- Blood Biomarkers Plus Gene Status Predict Cognitive Decline : Neurology Today
- Early Detection of Alzheimer’s Prior to Onset of Symptoms Now Possible | Science Times
- We Need New Ideas for Fighting Alzheimer’s | Scientific American
- Immune view offers clues to early Alzheimer’s